Medicus Sciences Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MSAC research report →
Price Chart
About the company
Medicus Sciences Acquisition Corp. , founded in 2020 and headquartered in New York, New York, currently has no substantial independent business activities. Its main goal is to execute a business combination—such as a merger, stock exchange, asset purchase, or reorganization—with one or more enterprises.
- CEO
- Jacob Jay Gottlieb
- IPO
- 2021
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on MSAC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $0
- P/E
- 56.50
- PEG
- 0.20
- P/S
- 0.00
- P/B
- 1.23
- EV/EBITDA
- 2.33
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 4.45%
- ROIC
- -0.66%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-615,000+0.0%
- Op Income
- $-615,000
- Net Income
- $1.90M+0.0%
- EPS
- $0.18+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $10.18
- 52W Low
- $9.72
- 50D MA
- $10.10
- 200D MA
- $9.93
- Beta
- 0.00
- RSI (14)
- 87
- Avg Volume
- 51.85K
No earnings-call transcripts are available for MSAC yet.
of shares held by institutions
54 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Knott David M | 200.00K | ▲ 200.00K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 12, 21 | Drillick Judah | other | 0 |
| Feb 12, 21 | Cheng Eric | other | 0 |
| Feb 12, 21 | Levine Ross | other | 0 |
| Feb 12, 21 | Berkovitz Kenneth | other | 0 |
| Feb 12, 21 | Kaster Christopher | other | 0 |
| Feb 12, 21 | Gottlieb Jacob | other | 1,161,500 |
| Feb 12, 21 | Castor Michael | other | 1,161,500 |
| Feb 12, 21 | Medicus Sciences Holdings LLC | other | 2,323,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MSAC coverage
Recent articles, reports, and earnings notes.
No research on MSAC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MSAC report →